These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1601361)

  • 41. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Paraclinical and clinical correlations on the implications of obesity in the pathogenesis of diabetes mellitus and atherosclerosis].
    Creţeanu G; Jalobceastâi D; Cepoi V; Beşchea M; Ursuleanu G; Stanciu R; Pleşcan C; Creţeanu M; Creţeanu G; Munteanu G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):307-12. PubMed ID: 4089333
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
    J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of various therapies on hyperlipidemia in diabetes mellitus.
    Calvert GD; Jenkins A; Abbey M
    Horm Metab Res Suppl; 1985; 15():94-8. PubMed ID: 3865889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W; Müller-Wieland D; Wirth H
    Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dyslipoproteinemia and diabetes.
    Garg A
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):613-25, ix-x. PubMed ID: 9785056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary hypertriglyceridemia and hyperlipoproteinemia in patients with primary asymptomatic gout.
    Naito HK; Mackenzie AH
    Clin Chem; 1979 Mar; 25(3):371-5. PubMed ID: 262176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is meant by overproduction of apo B-containing lipoproteins?
    Grundy SM; Vega GL
    Adv Exp Med Biol; 1991; 285():213-22. PubMed ID: 1858551
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood lipid characteristics of children with a hereditary disposition to diabetes mellitus].
    Ignatiuk TE; Marchenko LF; Ermolenko RI; Semenova EI; Turkina TI
    Pediatriia; 1987; (3):101-2. PubMed ID: 3601525
    [No Abstract]   [Full Text] [Related]  

  • 52. [Beta-glucuronidase in lymphocytes of patients with diabetes mellitus].
    Moszczyński P; Lisiewicz J; Palimaka W
    Endokrynol Pol; 1983; 34(2):81-6. PubMed ID: 6628334
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coagulant activity of platelets in obesity, dyslipidemias and diabetes].
    Jouve R; Juhan I; Boffa MC; Bartolin R; Heim M; Bouvenot G; Delboy C; Simonin R; Vague J
    Rev Med Interne; 1982 Mar; 3(1):37-42. PubMed ID: 7100695
    [No Abstract]   [Full Text] [Related]  

  • 54. [Polarization microscopy in diagnosis of metabolic disorders].
    Savina LV; Pavlishchuk SA; Samsygin VIu; Bolotova EV; Gotovtseva LP; Chekmareva SE; Nuzhnaia IA
    Klin Lab Diagn; 2003 Mar; (3):11-4. PubMed ID: 12715390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood lipid and protein levels in juvenile diabetes mellitus.
    TRAISMAN HS; NEWCOMB AL; SEVER JL; HAMMES R
    Diabetes; 1960; 9():481-4. PubMed ID: 13777832
    [No Abstract]   [Full Text] [Related]  

  • 56. Gout, diabetes mellitus and obesity, a poorly appreciated syndrome.
    ENGELHARDT HT; WAGNER EL
    South Med J; 1950 Jan; 43(1):51-3. PubMed ID: 15399098
    [No Abstract]   [Full Text] [Related]  

  • 57. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.
    VAGUE J
    Am J Clin Nutr; 1956; 4(1):20-34. PubMed ID: 13282851
    [No Abstract]   [Full Text] [Related]  

  • 58. THE DIABETIC SYNDROME. A HYPOTHETICAL MODEL.
    CROMBIE DL
    Lancet; 1964 Mar; 1(7334):627-9. PubMed ID: 14107927
    [No Abstract]   [Full Text] [Related]  

  • 59. [Digestive and metabolic diseases].
    LICKINT F
    Munch Med Wochenschr; 1960 Feb; 102():335-8. PubMed ID: 14416780
    [No Abstract]   [Full Text] [Related]  

  • 60. [Gastrointestinal and metabolic diseases].
    LICKINT F
    Munch Med Wochenschr; 1955 Nov; 97(45):1507-12. PubMed ID: 13288453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.